v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (11,208,195) $ (15,871,040)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 60,536 131,994
Stock-based compensation expense 6,138,216 10,532,034
Change in fair value of warrants (24,654) 7,553
Amortization of right-of-use asset 58,659 264,192
Change in operating assets and liabilities:    
Prepaid expenses and other assets 78,370 (297,763)
Other assets 9,957
Accounts payable (510,863) (959,943)
Accrued expenses and other liabilities (272,583) (71,206)
Operating lease liabilities (58,658) (243,544)
Net cash used in operating activities (5,739,172) (6,497,766)
Cash flows from investing activities:    
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from loan agreement 2,000,000 3,400,000
Proceeds from pre-funded warrants, net of offering costs 2,967,000
Proceeds from issuance of shares under the sales agreement, net of offering costs 1,301,955
Capital contribution 2,500,000
Net cash provided by financing activities 6,268,955 5,900,000
Net increase (decrease) in cash 529,783 (597,766)
Cash - beginning of period 552,372 1,282,995
Cash - end of period 1,082,155 685,229
Supplementary disclosure of noncash investing and financing activities:    
Issuance of shares in connection with the loan agreement 134,461
Deferred offering cost amortization 5,535
Receivables from issuance of shares under the sales agreement 18,064
Right-of-use assets obtained in exchange for operating lease liabilities $ 1,513,607